Neurokinin-receptor antagonists: Pharmacological tools and therapeutic drugs

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 6, 1997, Pages 612-621

  Longmore, J ^a   Hill, R G ^a   Hargreaves, R J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Central nervous system function; Emesis; Migraine; Neurokinin receptor antagonists; Nociception

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 2 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 4 (3 OXO 1,2,4 TRIAZOL 5 YLMETHYL) 3 PHENYLMORPHOLINE; 2 [3,5-BIS(TRIFLUOROMETHYL)BENZYLOXY] 4 [3 [5 OXO (1H,4H) 1,2,4 TRIAZOLO]METHYL] 3 PHENYLMORPHOLINE; 3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 OL; LANEPITANT; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ A; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; [2 METHOXY 5 (1 TETRAZOLYL)BENZYL](2 PHENYL 3 PIPERIDINYL)AMINE;

ANXIETY; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; MIGRAINE; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RECEPTOR DENSITY; SCHIZOPHRENIA; SPECIES DIFFERENCE; VOMITING;

EID: 0030722614     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-069     Document Type: Conference Paper

References (103)

1. 1 receptor antagonist SR140333 produces long lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 352: 201-205.
2. 2-receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum. J. Pharmacol. Exp. Ther. 274: 928-936.
3. 3 receptor antagonists. Edited by F.D. King, B.J. Jones, and G.J. Sanger. CRC Press, Boca Raton, Fla. pp. 255-317.
4. Beach, T.G., and McGeer, E.G. 1984. The distribution of substance P in the primate basal ganglia: an immunohistochemical study of baboon and human brain. Neuroscience, 13: 29-52.
5. 1-receptors by use of the non-peptide antagonist, CP-96,345. Br. J. Pharmacol. 104: 292-293.
6. 1 receptor antagonist, (±)-CP-96,345, produces antinociceptive and anti-odema effects in the rat. Br. J. Pharmacol. 105: 508-510.
7. Blau, J.N., and Dexter, S.L. 1981. The site of pain origin during migraine attacks. Cephalalgia, 1: 143-147.
8. 1 receptor antagonist, CP-99,994, in ferrets. Eur. J. Pharmacol. 249: R3-R4.
9. Brown, I.H. 1990. Atropine, scopolamine and related antimuscarinic drugs. In The pharmacological basis of therapeutics. Edited by A. Goodman Gilman, L.S. Goodman, and A. Gilman. Pergamon, New York. pp. 150-165.
10. Caeser, M., Seabrook, G.R., and Kemp, J.A. 1993. Block of voltage-operated sodium currents by the substance-P receptor antagonist (±)-CP-96,345 in neurones cultured from rat cortex. Br. J. Phar macol. 109: 918-924.
11. Carpenter, D.O., Briggs, D.B., and Strominger, N. 1984. Peptide induced emesis in dogs. Behav. Brain Res. 11: 277-281.
12. Cascieri, M.A., Huang, R.-R.C., Fong, T.M., Cheung, A.H., Sadowski, S., Ber, E., and Strader, C.D. 1992. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol. Pharmacol. 41: 1096-1099.
13. Cervero, F., and Laird, J.M.A. 1991. One pain or many pains? A new look at pain mechanisms. News Physiol. Sci. 6: 268-273.
14. Chang, M.M., Leeman, S.E., and Niahl, H.D. 1971. Aminoacid sequence of substance P. Nature (London), 232: 86-87.
15. 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci. Lett. 157: 149-152.
16. Cutrer, F.M., Moussaoui, S., Garrett, C., and Moskowitz, M.A. 1995. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation. Neuroscience, 64: 741-750.
17. de Koninck, Y., and Henry, J.L. 1991. Substance P-mediated slow excitatory potentials elicited in dorsal horn neurones in vivo by noxious stimulation. Proc. Natl. Acad. Sci. U.S.A. 88: 11 344-11 348.
18. Dietl, M.M., and Palacios, J.M. 1991. Phylogeny and tachykinin receptor localisation in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain. Brain Res. 539: 211-222.
19. 1 antagonist, CP-99,994, in comparison to ibuprofen and placebo in the oral surgery model. Clin. Pharmacol. Ther. 59: OIII-B-1.
20. Duggan, A.W., and Weihe, E. 1991. Central transmission of impulses in nociceptors: events in the superficial dorsal horn. In Towards a new pharmacotherapy of pain. Edited by A. Basbaum and J.M. Besson. John Wiley and Sons Ltd., Chichester. pp. 35-67.
21. Edvinsson, L. 1985. Functional role of perivascular peptides in the control of cerebral circulation. Trends Neurosci. 8:126-131.
22. Escott, K.J., Connor, H.E., Brain, S.D., and Beattie, D.T. 1995. The involvement of calcitonin gene-related peptide (CGRP) and substance P in feline pial artery diameter responses evoked by capsaicin. Neuropeptides, 29: 129-135.
23. 1 receptor antagonist GR203040. Br. J. Pharmacol. 116: 3158-3163.
24. Gasparovic, K., Hadzovic, S., and Stern, P. 1964. Contribution to the theory that substance P has a transmitter role in sensory pathways. Med. Exp. 10: 303-306.
25. Gillis, R.A., Helke, C.J., Hamilton, B.L., Norman, W.P., and Jacobwitz, D.W. 1980. Evidence that substance P is a neurotransmitter of baro- and chemoreceptor afferents in nucleus tractus solitarius. J. Brain Res. 181: 476-481.
26. Gitter, B.D., Waters, D.C., Bruns, R.F., Mason, N.R., Nixon, J.A., and Howbert, J.J. 1991. Species differences in affinities of nonpeptide antagonists for substance P receptors. Eur. J. Pharmacol. 197: 237-238.
27. Goadsby, P.J., Edvinsson, L., and Ekman, R. 1990. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28: 183-187.
28. Goldstein, D. 1996. Update on clinical trials with lanepitant (LY303870). Presented at Tachykinins and their Antagonists, William Harvey Research Conferences, 10-11 October 1996, London.
29. 2-receptor antagonists. Regul. Pept. 46: 9-19.
30. Hall, J. 1994 Peripheral role of receptors. In The tachykinin receptors. Edited by S. Buck. Humana Press, Totowa, N.J. pp. 515-579.
31. Handwerker, H.O., and Kobal, G. 1993. Psychophysiology of experimentally induced pain. Physiol. Rev. 73: 639-671.
32. Hill, R.G. 1986. Current perspectives on pain. Sci. Prog. (Oxford), 70: 95-107.
33. Hill, R.G. 1994. Role of receptors in nociception. In The tachykinin receptors. Edited by S. Buck. Humana Press, Totowa, N.J. pp. 471-497.
34. 1-receptor RP 67580 in inhibiting chemonociception. Br. J. Pharmacol. 115: 486-490.
35. Hornykiewicz, O. 1973. Dopamine in the basal ganglia: its role and therapeutic implications (including the clinical use of L-DOPA). Br. Med. Bull. 29: 172-178.
36. 1-receptor antagonist CP-99,994 on locomotor activity in guinea-pigs. Br. J. Pharmacol. 112: 51P.
37. Jansen, I., Alafaci, C., McCulloch, J., Uddman, R., and Edvinsson, L. 1991. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ. Cereb. Blood Flow Metab. 11: 567-575.
38. Jansen, I., Uddman, R., Ekman, R., Olesen, J., Ottoson, A., and Edvission, L. 1992. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides, 13: 527-536.
39. 1 receptors. Neuropharmacology, 33: 167-169.
40. Kalivas, P.W. 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18: 75-113.
41. Kelley, A.E., Stinus, L., and Iversen, S.D. 1979. Behavioural activation induced in the rat by substance P infusion into the ventral tegmental area: implication of dopaminergic AlO neurones. Neurosci. Lett. 11: 335-339.
42. Knox, A.P., Strominger, N.L., Battles, A.H., and Carpenter, D.O. 1993. Behavioural studies of emetic sensitivity in the ferret. Brain Res. Bull. 31: 477-484.
43. Kris, M.G., Radford, J., Pizzo, B., Inabinet, R., Lovelace, J., Casey, M., and Hesketh, P. 1996. Dose-ranging antiemetic trial of the NK-1 receptor antagonist CP-122,721: a new approach for acute and delayed emesis following cisplatin. Proc. Am. Soc. Clin. Oncol. 15. Abstr. 1780.
44. Kurosawa, M., Messlinger, K., Pawlak, M., and Schmidt, R.F. 1995. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br. J. Pharmacol. 114: 1397-1402.
45. Laird, J.M.A., Hargreaves, R.J., and Hill, R.G. 1993. Effect of RP67580, a non-peptide neurokinin-1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat. Br. J. Pharmacol. 109: 713-718.
46. Laneuville, O., Dorais, J., and Couture, R. 1988. Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat. Life Sci. 42: 1295-1305.
47. Lembeck, F. 1953. Zur frage der zentralen ubertragung afferenter inpulse. III. Mitteilung. Das vorkommen und die bedeutung der Substanz P in den dorsalen wurzeln des ruckenmarks. Arch. Exp. Pathol. Pharmakol. 219: 197-213.
48. Liu-Chen, L.-Y., Mayberg, M.R., and Moskowitz, M.A. 1983. Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats. Brain Res. 268: 162-166.
49. Longmore, J., Swain, C.J., and Hill, R.G. 1995. Neurokinin receptors. Drugs News Perspectives, 8: 5-23.
50. Lowe, J.A., III, and McLean, S. 1995. Tachykinin antagonists. Current Pharmaceutical Design, 1: 269-278.
51. Lundberg, J., Ahlman, H., Dahlstrom, A., and Kewenter, J. 1976. Catecholamine containing nerves in the human abdominal vagus. Scand. J. Gastroenterol. 70: 472-475.
52. Ma, Q.-P., and Woolf, C.J. 1995. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motoneurones. J. Physiol. (London), 486: 769-777.
53. Maggi, C.A., Patacchini, R., Rovero, P., and Giachetti, A. 1993. Tachykinin receptors and tachykinin receptor antagonists. Autonomic Pharmacol. 13: 23-93.
54. Mantyh, P.W., Gates, T., Mantyh, C.R., and Maggio, J.E. 1989. Autoradiographic localization and characterisation of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9: 258-279.
55. Marione, M., Armstrong, D.M., Young, S.J., and Groves, P.M. 1992. Ultrastructural examination of enkephalin and substance P inputs to cholinergic neurones within the rat neostriatum. Brain Res. 594: 253-262.
56. 3 (serotonin) antagonist ondansetron (GR3803F) with high-dose metoclopramide in the control of cisplatin-induced emesis. New Engl. J. Med. 322: 816-821.
57. McCarson, K.E., and Goldstein, B.D. 1990. Time course of the alteration in substance P levels in dorsal horn following formalin: blockade with naloxone. Pain, 41: 95-100.
58. Moskowitz, M.A. 1992. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13: 307-311.
59. Moskowitz, M.A., and Buzzi, M.G. 1991. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug action. J. Neurol. 238: S18-S22.
60. 1-receptor antagonists. In Headache treatment: trial methodology and new drugs. Edited by J. Olesen and P. Tefelt-Hanson. Lippincott-Raven, Philadelphia. pp. 303-311.
61. Newton, B.W., Maley, B., and Traurig, H. 1985. The distribution of substance P, enkephalin and serotonin immunoreactivities in the area postrema of the rat and cat. J. Comp. Neurol. 234: 87-104.
62. Nissila, M., Parkkola, R., Sonninen, P., and Saloene, R. 1996. Intracerebral arteries and gadolinium enhanced MRI in migraine without aura. Cephalalgia, 16: 15. (Suppl. XI Migraine Trust International Symposium, 9-12 September 1996.)
63. Olesen, I.J., and Edvinsson, L.I.H. 1995. Human cranial arteries as an in vitro model of migraine. In Experimental headache models. Edited by J. Olesen and M.A. Moskowitz. Lippincott-Raven Press, New York. pp. 143-151.
64. 1 receptors mediate plasma protein extravasation in guinea-pig dura. Eur. J. Pharmacol. 236: 319-321.
65. Otsuka, M., and Yoshioka, K. 1993. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73: 229-308.
66. Parent, A., Cicchetti, F., and Beach, T.G. 1995. Striatal neurones displaying substance P (NK1) receptor immunoreactivity in human and non human primates. NeuroReport, 6: 721-724.
67. 2 receptors in a spinal nociceptive reflex in the rat. Eur. J. Pharmacol. 232: 255-261.
68. Radhakrishnan, V., and Henry, J.L. 1991. Novel substance P antagonist, CP-96,345, blocks responses of cat spinal dorsal horn neurones to noxious cutaneous stimulation and to substance P. Neurosci. Lett. 132: 39-43.
69. Regoli, D., Boudon, A., and Fauchere, J.L. 1994. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46: 551-600.
70. Rupniak, N.M., and Jackson, A. 1994. Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs. Eur. J. Pharmacol. 262: 171-175.
71. 1-receptor antagonists: non-specific effects of racemic RP67580. Br. J. Pharmacol. 110: 1607-1613.
72. 1 receptor antagonist CP-99,994 in conscious gerbils. Br. J. Pharmacol. 116: 1937-1943.
73. 1 receptor antagonist L-733,060 in gerbils. Pain, 67: 189-195.
74. 3 ligands) in the rat brain. Peptides, 9: 227-241.
75. Saito, K., Greenberg, S., and Moskowitz, M.A. 1987. Trigeminal origin of β-preprotachykinin products in feline pial blood vessels. Neurosci. Lett. 76: 69-73.
76. Salt, T.E., and Hill, R.G. 1983. Neurotransmitter candidates of somatosensory primary afferent fibres. Neuroscience, 10: 1083-1103.
77. Sarau, H.M., Griswold, D.E., Foley, J.J., Schmidt, D.B., Martin, L.D., Giardina, G., and Hay, D.H.M. 1996. Pharmacology of SB 223412, a selective high affinity orally active non-peptide NK-3 receptor antagonist. Peptide Receptor Symposium, Montréal, Que. Abstract VIII.0.1.
78. Seabrook, G.R., Bowery, B.J., and Hill, R.G. 1995. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Eur. J. Pharmacol. 273: 113-119.
79. 1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br. J. Pharmacol. 108: 11-12.
80. 1 receptor antagonist CP-99,994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology, 34: 255-261.
81. 2-receptor antagonists in the mouse light-dark box. Eur. J. Pharmacol. 250: R11-R12.
82. 3H]SR48968. Br. J. Pharmacol. 117: 295P.
83. Stubbs, C.M., Waldron, G.J., Connor, H.E, and Feniuk, W. 1992. Characterisation of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation. Br. J. Pharmacol. 105: 875-880.
84. Swain, C.J., and Hargreaves, R.J. 1996. Neurokinin receptor antagonists. Annu. Rep. Med. Chem. 31: 111-120.
85. Tamiya, R., Hanada, M., Kawai, Y., Inagaki, S., and Takagi, H. 1990. Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat. Neurosci. Lett. 110: 11-15.
86. 1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. Eur. J. Pharmacol. 250: R5-R6.
87. 1 receptor antagonist CP-99,994. Neuropharmacology, 33: 259-260.
88. 1) receptor antagonist CP-99,994. Neuropharmacology, 34: 1697-1699.
89. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology, 35: 1121-1129.
90. Tattersall, F.D., Rycroft, W., Ber, E., Cascieri, M., Hale J., Hill, R.G., MacCoss, M., Mills, S., Sadowski, S., and Hargreaves, R.J. 1996b. The NK-1 receptor antagonist L-742,694 has activity against both centrally and peripherally-induced emesis in ferrets. Peptide Receptor Symposium, Montréal, Que. Abstr. P4.5.
91. Uddman, R., and Edvinsson, L. 1989. Neuropeptides in the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1: 230-252.
92. von Euler, U.S., and Gaddum, J.H. 1931. An unidentified depressor substance in certain tissue extracts. J. Physiol. (London), 72: 74-89.
93. 2-receptor antagonist, in rodent and primate models of anxiety. Psychopharmacology, 121: 186-191.
94. 1-receptor antagonist, (2S,3S)-(2-methoxy-5-tetrazol-1-ylbenzyl)-(2-phenylpiperidin-3-yl)amine (GR203040), with potent anti-emetic activity. J. Med. Chem. 38: 4985-4992.
95. 1-receptor. Br. J. Pharmacol. 115: 84-94.
96. Watson, J.W., Nagahisa, A., Lucot, J.B., and Andrews, P.L.R. 1995b. The tachykinins and emesis: towards complete control? In Serotonin and the scientific basis of anti-emetic therapy. Edited by D.J.M. Reynolds, P.L.R. Andrews, and C.J. Davis. Oxford Clinical Communications, Oxford. pp. 233-238.
97. Weihe, E. 1990. Neuropeptides in primary afferent neurones. In The primary afferent neurone. Edited by W. Zenker and W. Neuhuber. Plenum, New York. pp. 127-159.
98. Whitty, C.J., Walker, P.D., Goebel, D.J., Poosch, M.S., and Bannon, M.J. 1995. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience, 64: 419-425.
99. Williamson, D.J., Hargreaves, R.J., and Hill, R.G. 1996. Direct measurement of durai vessel diameter in the rat using intra vital microscopy. Br. J. Pharmacol. 117: 271P.
100. Xu, X.J., Dalsgaard, C.-J., and Wiesenfeld-Hallin, Z. 1992. Intrathecal CP-96,345 blocks reflex facilitation induced in rats by substance P and C-fiber-conditioning stimulation. Eur. J. Pharmacol. 216: 337-344.
101. 1 selective antagonist, CP-96,345: antinociception in the absence of motor disfunction. Life Sci. 49: 1955-1963.
102. Yashpal, K., Radhakrishnan, V., Coderre, T.J., and Henry, J.L. 1993. CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience, 52: 1039-1047.
103. Zerari, F., Dion, S., Karpitskiy, V., Krause, J., and Couture, R. 1996. Immunocytochemical localization of tachykinin NK-2 receptors (NK-2R) in the rat central nervous system (CNS). Peptide Receptor Symposium, Montréal, Que. Abstr. VI.0.5.